Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients
Condition(s):Alzheimer’s DiseaseLast Updated:July 16, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:July 16, 2010Unknown status
Condition(s):Overactive BladderLast Updated:January 12, 2015Unknown status
Condition(s):Allergic RhinitisLast Updated:June 18, 2023Recruiting
Condition(s):Traumatic Brain InjuryLast Updated:November 1, 2017Completed
Condition(s):Acute Ischemic StrokeLast Updated:August 31, 2021Completed
Condition(s):Neurotrophic KeratopathyLast Updated:March 5, 2020Completed
Condition(s):Alcohol-induced Brain InjuryLast Updated:October 27, 2020Unknown status
Condition(s):Injury of Optic NerveLast Updated:August 17, 2021Unknown status
Condition(s):Cerebral Small Vessel DiseasesLast Updated:November 2, 2020Unknown status
Condition(s):Retinitis Pigmentosa; Cystoid Macular EdemaLast Updated:September 6, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.